scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JMB.2003.12.005 |
P698 | PubMed publication ID | 14741214 |
P50 | author | Alan Fersht | Q537479 |
P2093 | author name string | Assaf Friedler | |
Stefan M V Freund | |||
Stefan Rüdiger | |||
Brian S DeDecker | |||
Caroline Blair | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 187-196 | |
P577 | publication date | 2004-02-01 | |
P1433 | published in | Journal of Molecular Biology | Q925779 |
P1476 | title | Structural distortion of p53 by the mutation R249S and its rescue by a designed peptide: implications for "mutant conformation". | |
P478 | volume | 336 |
Q56341291 | Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer |
Q51564147 | Binding of Rad51 and other peptide sequences to a promiscuous, highly electrostatic binding site in p53. |
Q34412989 | Biopharmaceuticals and monoclonal antibodies in oncology trials--a cross-sectional analysis |
Q38472585 | Compensated pathogenic deviations |
Q50051527 | Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles |
Q92293773 | Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem Cells |
Q37808312 | From peptides to proteins: lessons from my years at the Centre for Protein Engineering |
Q84551753 | Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions |
Q47789753 | Insights into the Effect of the G245S Single Point Mutation on the Structure of p53 and the Binding of the Protein to DNA. |
Q41677793 | Multisite aggregation of p53 and implications for drug rescue |
Q57950380 | Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights |
Q44145204 | QM-MM simulations on p53-DNA complex: a study of hot spot and rescue mutants |
Q30009903 | Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism |
Q36710840 | Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. |
Q33795918 | SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53 |
Q58740843 | Skeletal Muscle Dystrophy mutant of lamin A alters the structure and dynamics of the Ig fold domain |
Q33322204 | Stability of the core domain of p53: insights from computer simulations |
Q36786022 | Structural biology of the tumor suppressor p53 and cancer-associated mutants |
Q35051686 | Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain |
Q36777367 | Structure-function-rescue: the diverse nature of common p53 cancer mutants |
Q45259201 | Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations |
Q37855887 | Using peptides to study protein-protein interactions |
Q36764842 | p53 gene in treatment of hepatic carcinoma: status quo. |
Search more.